PI-PLCbeta-1 and activated Akt levels are linked to azacitidine responsiveness in high-risk myelodysplastic syndromes (Q80599609)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17625605%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

title

PI-PLCbeta-1 and activated Akt levels are linked to azacitidine responsiveness in high-risk myelodysplastic syndromes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17625605%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17625605%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Follo MY

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17625605%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Finelli C

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17625605%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Bosi C

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17625605%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Martinelli G

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17625605%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Mongiorgi S

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17625605%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Baccarani M

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17625605%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Manzoli L

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17625605%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Martelli AM

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17625605%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Cocco L

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17625605%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

publication date

12 July 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17625605%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17625605%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17625605%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17625605%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

page(s)

198-200

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17625605%20AND%20SRC:MED&resulttype=core&format=json

Signal transduction within the nucleus: revisiting phosphoinositide inositide-specific phospholipase Cbeta1.

2 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404855

7 January 2021

Inositide-specific phospholipase c beta1 gene deletion in the progression of myelodysplastic syndrome to acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404855

7 January 2021

The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404855

7 January 2021

Approval summary: azacitidine for treatment of myelodysplastic syndrome subtypes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404855

7 January 2021

Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404855

7 January 2021

Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2'-deoxycytidine (decitabine) treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404855

7 January 2021

Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404855

7 January 2021